CURRICULUM VITAE Revised 12/2014

Sherif I. Heiba, M.D.

ACADEMIC APPOINTMENTS

3/06 till present Associate Professor of Radiology

Mount Sinai School of Medicine

New York, NY

10/03 – 2/06 Associate Professor of Radiology

New York Medical College

New York, NY

7/99 – 9/03 Assistant Professor of Radiology

New York Medical College

New York, NY

1/95 –6/99 Assistant Professor,

Department of Nuclear Medicine

Faculty of Medicine

Kuwait University

7/93 – 12/94 Instructor, Division of Nuclear Medicine

University of Washington School of Medicine

Seattle, Washington

HOSPITAL APPOINTMENTS

3/06 till present Attending Physician, Department of Radiology

Mount Sinai Medical Center

New York, NY

7/99 – 2/06 Assistant Director, Nuclear Medicine Division,

Department of Radiology

Saint Vincent’s Hospital and Medical Center

New York, NY

1/95 – 6/99 Consultant and Vice Chairman,

Nuclear Medicine Department

Mubarak Al-Kabeer Hospital

Kuwait City, Kuwait

7/93 –12/94 Assistant Director, Research Radionuclide Laboratory,

Attending Physician,

Division of Nuclear Medicine

Veterans Administration Medical Center

Seattle, Washington

7-12/1990 Admitting Physician of Ambulatory Care. Veterans Administration Medical Center - Tucson, Arizona.

DEPARTMENTAL RESPONSIBILITIES

3/06 till Present Director, Nuclear Medicine Residency Program,

Department of Radiology

Mount Sinai School of Medicine

New York, NY

EDUCATION

9/71 – 1/78 Medical School, Alexandria University Faculty of Medicine

Alexandria, Egypt

POSTGRADUATE TRAINING

1991 - 1993 Fellow - Nuclear Cardiology/Nuclear Medicine. University of Washington Medical Center - Seattle, Washington

1988 -1991 Resident - Internal Medicine. University of Arizona Health Sciences Center - Tucson, Arizona

1986 - 1988 Resident - Nuclear Medicine. University of Miami/Jackson Memorial Hospital - Miami, Florida

CERTIFICATIONS

2011 Recertification, American Board of Nuclear Medicine # 05746

2002 Recertification, American Board of Nuclear Medicine # 05746

2000 Diplomat, Certification Board of Nuclear Cardiology # 1708

1992 Diplomat, American Board of Nuclear Medicine # 05746

1991 Diplomat, American Board of Internal Medicine # 135616

1989 Federation Licensing Examination (FLEX)

1983 Education Commission for Foreign Medical Graduates (ECFMG)

Certification #335-023-8

1982 Visa Qualifying Examination (VQE)

1978 Medical Diploma (M.B., Ch.B.)

LICENSURE

2008 Pennsylvania # MD434154

1999 New York # 213637

1996 California # A060904

1991 Washington # 28517

1990 Arizona # 19320

1989 Florida # 55103

HONORS

Asa E. Seeds Award of Nuclear Medicine, Washington 1993

Chief Resident of Nuclear Medicine University of Miami/Jackson

Memorial Medical Center; July 1987 - June 1988

Graduated from Medical School in Top 10%

Graduated from High School with honors; 7th in Nation

PROFESSIONAL SOCIETIES

Society of Nuclear Medicine

American Society of Nuclear Cardiology

American College of Physicians

American College of Nuclear Physicians

American Medical Association

GRANTS AND CONTRACT SUPPORT

PREVIOUS GRANT AND CONTRACT SUPPORT

List Funding Source, Project Title & Number / Role in Project / Dates / Direct Costs / Supplemental Info
Funding Source: King Pharmaceuticals Research and Development, Inc
Study Title: Randomized, single blinded, two-arm crossover, dose-selection study of MRE0470 as an adjunct to myocardial perfusion imaging / Role:
Co-Investigator
PI:
James E. Udelson, MD / 2001-2002
List Funding Source, Project Title & Number / Role in Project / Dates / Direct Costs / Supplemental Info
Funding Source: King Pharmaceuticals Research and Development, Inc.
Study Title: Vasodilator Induced Stress In CONcordance with Adenosine
(VISION-301) / Role:
Co-Investigator
PI: James E. Udelson, MD / 2002– 2003
List Funding Source, Project Title & Number / Role in Project / Dates / Direct Costs / Supplemental Info
Funding Source: Bristol-Myers Squibb Medical Imaging, Inc
Study Title: Low dose dobutamine Nitrate-Enhanced Rest/Stress Tc-99m Sestamibi Protocol (CG# 23019) / Role:
Principle Investigator / 2003– 2005
List Funding Source, Project Title & Number / Role in Project / Dates / Direct Costs / Supplemental Info
Funding Source: Blood and Cancer Research Fund, New York, NY.
Study Title: Evaluation of therapy response using FDG PET/CT in patients with multiple
myeloma undergoing bone marrow transplantation
GCO# 08-0013 / Role: Co-Investigator
PI: Lale Kostakoglu, M.D.
Mount Sinai Medical Center
New York, NY / 2007-2010
List Funding Source, Project Title & Number / Role in Project / Dates / Direct Costs / Supplemental Info
Funding Source: Mount Sinai School Of Medicine.
Study Title: A Combined Evaluation Strategy of F-18 FDG PET/CT and Contrast-Enhanced Diagnostic CT for Lymph Nodes in the Neck
GCO# 11-0189-00001-01-PD / Role: Co-Investigator
PI: Lale Kostakoglu, M.D.
Mount Sinai Medical Center
New York, NY / 2010-2011

CURRENT GRANT AND CONTRACT SUPPORT

List Funding Source, Project Title & Number / Role in Project / Dates / Direct Costs / Supplemental Info
Funding Source: Mount Sinai School Of Medicine
Study Title: An evaluation of the utility of dual-isotope SPECT/CT for localizing infections in the diabetic foot
GCO# 09-0691-00001-04-PD / Role: Principal Investigator
Sherif Heiba, M.D.
Mount Sinai Medical Center
New York, NY / 2008-2012
List Funding Source, Project Title & Number / Role in Project / Dates / Direct Costs / Supplemental Info
Funding Source: Mount Sinai School Of Medicine
Study Title: The incremental value of SPECT/CT Imaging to thyroid gland/dual phase Sestamibi pinhole imaging in the evaluation of primary hyperparathyroidism Patients.
GCO# 09-1805-00001-04-PD / Role: Principal Investigator
Sherif Heiba, M.D.
Mount Sinai Medical Center
New York, NY / 2009-2012
List Funding Source, Project Title & Number / Role in Project / Dates / Direct Costs / Supplemental Info
Funding Source: Surefire Medical, Inc.
Study Title: Coiling the GDA vs. Surefire During Y90 Infusion: The COSY Trial
GCO# / Role: Co-Investigator
PI: AARON M FISCHMAN, M.D.
Mount Sinai Medical Center
New York, NY / 2012-2013
List Funding Source, Project Title & Number / Role in Project / Dates / Direct Costs / Supplemental Info
Funding Source: Nordion
Study Title: Phase III Clinical Trial Evaluating TheraSphere® in Patients with Metastatic Colorectal Carcinoma of the Liver who have Failed First Line Chemotherapy
GCO# 12-1658-00001-01-PD / Role: Co-Investigator
PI: RANDALL F HOLCOMBE, M.D.
Mount Sinai Medical Center
New York, NY / 2012-2013
List Funding Source, Project Title & Number / Role in Project / Dates / Direct Costs / Supplemental Info
Funding Source: Aposense.
Study Title: A Prospective, Multicenter Study, to Evaluate the Efficacy and Safety of (18F)-ML-10, a PET Imaging Radiotracer, in Early Detection of Response of Non-Hematological Tumors to Concurrent Chemoradiotherapy
GCO# 10-0926-00001-03-PD / Role: Co-Investigator
PI: Lale Kostakoglu, M.D.
Mount Sinai Medical Center
New York, NY / 2012-2013
List Funding Source, Project Title & Number / Role in Project / Dates / Direct Costs / Supplemental Info
Funding Source: Mount Sinai School Of Medicine.
Study Title: PET/CT imaging for the assessment of bio-distribution of yttrium-90 (Y-90) in patients with unresectable hepatic tumors who have received intra arterial radioembolization therapy with Y-90 microspheres
GCO# 12-0560-00001-01-PD / Role: Co-Investigator
PI: JOSEF MACHAC, M.D.
Mount Sinai Medical Center
New York, NY / 2012-2013
List Funding Source, Project Title & Number / Role in Project / Dates / Direct Costs / Supplemental Info
Funding Source: Medivation.
Study Title: PREVAIL: A Multinational Phase 3, Randomized, Double-Blind, Placebo-Controlled Efficacy and Safety Study of Oral MDV3100 in Chemotherapy-Naive Patients with Progressive Metastatic Prostate Cancer Who Have Failed Androgen Deprivation Therapy
GCO# 10-1535-00001-02-PD / Role: Co-Investigator
PI: Simon J Hall, M.D.
Mount Sinai Medical Center
New York, NY / 2010-2012
List Funding Source, Project Title & Number / Role in Project / Dates / Direct Costs / Supplemental Info
Funding Source: Mount Sinai School Of Medicine.
Study Title: 4-Dimensional CT scanning versus conventional Sestamibi scanning or CT scanning for the localization of hyperfunctioning parathyroid glands
GCO# 10-1103-00001-02-PD / Role: Co-Investigator
PI: Randall P Owen, M.D.
Mount Sinai Medical Center
New York, NY / 2009-2012

TEACHING ACTIVITIES

TEACHING ACTIVITY/ TOPIC / LEVEL / ROLE / NUMBER OF LEARNERS / NUMBER OF HOURS PER WEEK/MONTH/YEAR / YEARS TAUGHT
Nuclear Cardiology Training of Cardiology Fellows / Divisions of Nuclear Medicine and Cardiology,
University of Washington / Instructor / 30 / 6 hr/yr / 1993-1994
Conferences to Radiology and Nuclear Medicine Residents / Division of Nuclear Medicine,
University of Washington / Instructor / 25 / 5 hrs/yr / 1993-1994
Nuclear Cardiology Course for Medical Students / University of Washington School of Medicine Course / Instructor / 40 / 4 hr/yr / 1993-1994
Medical Students Nuclear Medicine Introduction Course / Kuwait University, Faculty of Medicine
Course / Teaching/
Attending / 30 / 6 hrs/yr / 1995 – 1999
Medical Students Surgical/Nuclear Medicine Seminars / Kuwait University, Faculty of Medicine Course / Teaching/
Attending / 30 / 5 hrs/yr / 1996 – 1999
nuclear cardiology in postgraduate
cardiology program / Kuwait University, Faculty of Medicine / Teaching/
Attending / 10 / 5 hrs/yr / 1997 – 1999
Tutorial lectures
for radiology and nuclear medicine residents / Department
of Radiology,
New York Medical College / Teaching/
Attending / 20 / 6 hrs/yr / 1999-2005
Case conference
For nuclear medicine residents / Division of Nuclear Medicine, New York Medical College / Teaching/
Attending / 3 / 1 hr/mo / 1999-2005
Nuclear Cardiology lectures for Cardiology fellows / Division of Cardiology,
New York Medical College / Teaching / 20 / 4 hrs/yr / 2001-2005
General PET/CT sessions / Division of Nuclear Medicine / Attending / 2 / 3 hr/wk / 2006-2014
General Nuclear Medicine sessions / Division of Nuclear Medicine / Attending / 3 / 6 hr/wk / 2006-2014
Grand Rounds,
Radionuclide Investigations of the Urinary Tract / Department of
Urology / Teaching/
Attending / 40 / 1 hr / 2007
Medical Grand Rounds / Department of
Medicine, Division of Pediatric Nephrology / Teaching/
Attending / 7 / 1 hr / 2007
Journal Club / Division of Nuclear Medicine / Attending / 12 / 4 hr/yr / 2006-2014
Grand Rounds / Division of Nuclear Medicine / Teaching/
Attending / 12 / 2 hr/yr / 2006-2014
Case conference
For nuclear medicine residents / Division of Nuclear Medicine / Teaching/
Attending / 5 / 1 hr/mo / 2006-2012
Boards Review
for radiology residents / Department
of Radiology / Teaching/
Attending / 9 / 2 hr/yr / 2006-2012
Tutorial lectures
for radiology and nuclear medicine residents / Department
of Radiology / Teaching/
Attending / 18 / 12 hr/yr / 2006-2014
Research conferences / Division of Nuclear Medicine / Teaching/
Attending / 12 / 2 hr/yr / 2006-2014
Nuclear Medicine tutorial to medical students in anatomic radiology clerkship / Mount Sinai School of Medicine Course / Teaching/
Attending / 30 / 6 hrs/yr / 2006-2008
Nuclear Medicine tutorial to medical students in anatomic radiology clerkship / Mount Sinai School of Medicine Course / Teaching/
Attending / 20 / 3 hrs/yr / 2009-2014
Nuclear Medicine Residency Program / Mount Sinai School of Medicine,
Post graduate Program / Director / 4 / 8 hrs/wk / 2006-2014

PUBLICATIONS

Peer Reviewed Original Articles

Heiba S, Jiang M, Rivera J, Genden E, Inabnet III W, Machac J, Kostakoglu L. Direct comparison of neck pinhole dual tracer & dual phase sestamibi accuracies with and without SPECT/CT for parathyroid adenoma detection and localization. Clin Nucl Med. Revision under review. 2015.

Heiba, S, Kolker, D, Ong, L, Sharma, S, Travis, A, Teodorescu, V, Ellozy, S, Kostakoglu, L, Savitch, I, Machac, J. Dual-isotope SPECT/CT impact on hospitalized patients with suspected diabetic foot infection: saving limbs, lives, and resources. Nucl Med Commun. 2013;34:877-884.

Jiang M, Fischman A, Nowakowski SF, Heiba S, Zhang Z, Knesaurek K, Weintraub J and Machac J. Segmental perfusion differences on paired Tc-99m macroaggregated albumin hepatic perfusion imaging and yttrium-90 bremsstrahlung imaging studies in SIR-Sphere radioembolization:

Associations with angiography. J Nucl Med Radiat Ther. 2012;3:1-5.

Jiang M, Nowakowski FS, Wang J, Heiba S, Zhang Z, Weintraub J, Kim E, Machac J. Characterization of Extrahepatic Distribution of Tc-99m Macroaggregated Albumin in Hepatic Perfusion Imaging Studies Prior to Yttrium-90 Microsphere Therapy. Cancer Biotherapy & Radiopharmaceuticals 2011, 26: 511-518.

Heiba SI, Kolker D, Mocherla B, Kapoor K, Jiang M, Son H, Rangaswamy B, Kostakoglu L, Savitch I, DaCosta M, Machac M. The optimized evaluation of diabetic foot infection by dual isotope SPECT/CT imaging protocol. J Foot Ankle Surg 2010;49:529-36.

Knešaurek K, Machac J, Muzinic M, DaCosta M, Zhang Z, Heiba S. Quantitative Comparison of yttrium-90 (90Y)-microspheres and Technetium-99m (99mTc)-macroaggregated Albumin SPECT Images for Planning 90Y Therapy of Liver Cancer. Tech Cancer Res Treat 2010;9:253-261.

Heiba SI, Raphael B, Castellon I, Altinyay E, Sandella N, Rosen G, Abdel-Dayem HM. PET/CT image fusion error due to urinary bladder filling changes: consequence and correction. Ann Nucl Med 2009;23:739-744.

Wiseman GA, Pacak K, O'Dorisio MS, Neumann DR, Waxman AD, Mankoff DA, Heiba SI, Serafini AN, Tumeh SS, Khutoryansky N, Jacobson AF. Usefulness of 123I-MIBG scintigraphy in the evaluation of patients with known or suspected primary or metastatic pheochromocytoma or paraganglioma: results from a prospective multicenter trial. J Nucl Med 2009;50:1448-1454.

Vik TA, Pfluger T, Kadota R, Castel V, Tulchinsky M, Farto JC, Heiba S, Serafini A, Tumeh S, Khutoryansky N, Jacobson AF. (123)I-mIBG scintigraphy in patients with known or suspected neuroblastoma: Results from a prospective multicenter trial. Pediatr Blood Cancer 2009;52:784-790.

Heiba SI, Yee G, Abdel-Dayem HM, Youssef I, Coppola J. Combined rest redistribution thallium-201 SPECT and low-dose dobutamine contractility assessment in a simple and practical new viability protocol. Ann Nucl Med. 2009;23:197-203.

Berson AM, Stein NF, Riegel AC, Destian S, Ng T, Tena LB, Mitnick RJ and Heiba SI. Variability of gross tumor volume delineation in head-and-neck cancer using PET/CT fusion, part II: The impact of a contouring protocol. Med Dosim. 2009;34:30-35.

Piperkova E, Raphael B, Altinyay ME, Castellon I, Libes R, Sandella N, Heiba S, Abdel-Dayem H. Impact of PET/CT in comparison with same day contrast enhanced CT in breast cancer management. Clin Nucl Med 2007;32:429-434.

Elgazzar AH, Loutfi I, Baqer M, Farghali M, Khadada M, Heiba S, Uza O, Mahussein S, Al-Tailji S. Post-test probability for pulmonary embolism after ventilation-perfusion scan assessed by nuclear medicine physicians.

Med Princ Pract 2005;14:217-220

Heiba SI, Abdel-Dayem HA, Gould R, Bernaski E, Morlote M, El-Zeftawy H and Ambrose JA. Value of low dose dobutamine addition to routine dual isotope gated SPECT myocardial imaging in patients with healed myocardial infarction or abnormal wall thickening by echocardiogram. Am J Cardiol 2004;93:300-306.